NeuroMetrix Ordered to Pay $4 Million for Deceptive Advertising

By Sam | April 15, 2020

Under a settlement with the Federal Trade Commission, devicemaker NeuroMetrix agreed to pay at least $4 million and stop making deceptive claims that its Quell transcutaneous electrical nerve stimulation device treats pain throughout the body when placed below the knee.
Source: The GMP Letter

Posted in The GMP Letter